𝔖 Bobbio Scriptorium
✦   LIBER   ✦

What predicts mucosal inflammation in Crohn's disease patients?

✍ Scribed by Itta M. Minderhoud; Melvin Samsom; Bas Oldenburg


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
83 KB
Volume
13
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

✦ Synopsis


A number of disease-specific instruments have been created over the last 30 years to assess disease activity in Crohn's disease (CD). These disease activity indices are constituted of clinical and laboratory parameters and their role in predicting disease activity and the course of disease has been reviewed various times. Currently, the severity of mucosal inflammation, assessed by endoscopy, is considered the gold standard for disease activity in CD. In the present review the most frequently used endoscopic disease activity indices and the correlation between mucosal inflammation and clinical disease activity indices, quality of life questionnaires, and biochemical markers is critically appraised. We conclude that no clinical disease activity index or single laboratory parameter of inflammation reliably predicts the mucosal inflammatory disease activity. A new, easy-to-use and robust activity index predicting mucosal inflammation is highly needed to assess the response to investigational drugs in trials and the effect of therapeutical interventions in clinical practice.


πŸ“œ SIMILAR VOLUMES


Mucosal healing predicts long-term outco
✍ Fabian Schnitzler; Herma Fidder; Marc Ferrante; Maja Noman; Ingrid Arijs; Gert V πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 395 KB πŸ‘ 2 views

Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease (CD) but the impact of MH on the long-term outcome of IFX treatment in CD is still debated. ## Methods: We studied MH during long-term treatment with IFX in 214 CD patients. A total of 183 patients

Predictive value of mucosal TNF-Ξ± transc
✍ Carsten Schmidt; Thomas Giese; Eva Hermann; Stefan Zeuzem; Stefan C. Meuer; Andr πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 101 KB

Background: Concentrations of proinflammatory cytokines are increased in the intestinal mucosa of patients with active Crohn's disease (CD). In a prospective study we investigated whether cytokines can predict long-term remission (ΟΎ6 months) in patients with steroid-refractory CD receiving treatment

Factors predicting the outcome of diseas
✍ Henrik Stjernman; Curt Tysk; Sven Almer; Magnus StrΓΆm; Henrik Hjortswang πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 174 KB πŸ‘ 1 views

Background: The Crohn's Disease Activity Index (CDAI) has become the gold standard for assessment of disease activity in CD. This study investigated the relationship between CDAI and the physicians' global assessment of disease activity (PGA) and whether different demographic and disease-related fac

Risk factors for metabolic bone disease
✍ MarΓ­lia Cravo; Catarina Sousa Guerreiro; Paula Moura dos Santos; Miguel Brito; P πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 2 views

## Background: The aim was to evaluate the presence of metabolic bone disease (MBD) in patients with Crohn's disease (CD) and to identify potential etiologic factors. ## Methods: The case-control study included 99 patients with CD and 56 controls with a similar age and gender distribution. Both

Thrombin generation in pediatric patient
✍ Heike Bernhard; Andrea Deutschmann; Bettina Leschnik; Sabrina Schweintzger; Mich πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 291 KB πŸ‘ 2 views

Background: Patients with inflammatory bowel disease (IBD) have an increased risk of thromboembolic complications. The pathogenesis of IBD is not really clear and a high thrombin activity might contribute to the pathogenesis. We measured thrombin generation by means of calibrated automated thrombogr